MEDVi
Compounded + Brand-Name (Split Membership)From $299–$399/mo
Available in 49 states; now offers brand-name Wegovy and Zepbound alongside compounded options.
Visit MEDVi →Pros
- Available in 49 states — broadest coverage of any GLP-1 telehealth platform
- Now stocks brand-name Wegovy Pill, Wegovy Injection, and Zepbound Injection on a $99/mo membership tier
- Compounded options remain all-inclusive with no separate membership fee
- LegitScript certified; 11,000+ Trustpilot reviews at 4.4 stars
- Offers both injectable and tablet formulations of semaglutide and tirzepatide
- 24/7 messaging and unlimited telehealth consultations included
Cons
- FDA warning letter (Feb 2026) for misbranding — compounded medication marketed without clearly attributing the dispensing pharmacy
- Refill pricing on compounded sema ($299/mo) higher than introductory rate ($179/mo)
- Brand-name medication pricing not displayed publicly — surfaces after intake
- Compounded medications are not FDA-approved as finished products
Details
- Medications offered
- Compounded Sema, Compounded Tirz, Wegovy, Zepbound
- State availability
- All 50 states
- Affiliate partnership
- No
- Data verified
- 2026-05-07